Prostacyclin induces a surprising long-lasting motility in quiescent uterine strips (indomethacin-treated) isolated from ovariectomized rats

Dose-response curves for several prostaglandins (PGI2; PGD2; PGF2 and PGE2); BaCl2 or prostaglandin metabolites (15-keto-PGF2α; 13, 14-diOH-15-keto-PGF2α; 6-keto-PGF1α and 6-keto-PGE1 in quiescent (indomethacin-treated) uterine strips from ovariectomized rats, were constructed. All PGs tested as wel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Gimeno, A.L
Otros Autores: Chaud, M., Bonacossa, A., Franchi, A.M, Gimeno, M.F
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1983
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 09864caa a22011417a 4500
001 PAPER-18384
003 AR-BaUEN
005 20230518204945.0
008 190411s1983 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0021048161 
024 7 |2 cas  |a barium chloride, 10361-37-2; indometacin, 53-86-1, 74252-25-8, 7681-54-1; prostacyclin, 35121-78-9, 61849-14-7; prostaglandin D2, 41598-07-6; prostaglandin E2, 363-24-6; prostaglandin F2 alpha, 551-11-1; Barium, 7440-39-3; Barium Compounds; Chlorides; Dinoprost, 551-11-1; Dinoprostone, 363-24-6; Epoprostenol, 35121-78-9; Indomethacin, 53-86-1; Prostaglandin D2, 41598-07-6; Prostaglandins D; Prostaglandins E; Prostaglandins F; barium chloride, 10361-37-2 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a PRGLB 
100 1 |a Gimeno, A.L. 
245 1 0 |a Prostacyclin induces a surprising long-lasting motility in quiescent uterine strips (indomethacin-treated) isolated from ovariectomized rats 
260 |c 1983 
270 1 0 |m Gimeno, A.L.; Centro de Estudios Farmacológicos y de Principios Naturales (CEFAPRIN), Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET). Serr, 1414 Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Moncada, Gryglewski, Bunting, Vane, An enzyme isolated from arteries transform prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation (1976) Nature (Lond.), 263, p. 663 
504 |a Johnson, Norton, Kinner, Gorman, McGuirre, Sun, Whittaker, Vane, The chemical characterization of prostaglandin X (prostacyclin) (1976) Prostaglandins, 12, p. 915 
504 |a Williams, Demnibska-Kiéc, Zmuda, Gryglewski, Prostacyclin formation by myometrial and decidual fractions of the pregnant rat uterus (1978) Prostaglandins, 15, p. 343 
504 |a El-Tahir, Williams, Studies on prostacyclin formation by the rat pregnant myometrium (1980) Br. J. Pharmac., 70, p. 85P 
504 |a Gimeno, Borda, Lazzari, Gimeno, Ovarian hormones inhibit the release of prostacyclin like material from isolated rat uterus (1980) Prostaglandins, 20, p. 223 
504 |a Mitchell, Flint, Hicke, Kinston, Thorburn, Robinson, Uterine tissues from pregnant goats produce 6-oxo-prostaglandin F1 in vitro (1978) J. Endocr., 79, p. 401 
504 |a Fenwick, Jones, Naylor, Poyser, Wilson, Production of prostaglandins by the pseudo pregnant rat uterus in vitro and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1 as a major product (1977) Br. J. Pharmacol., 59, p. 191 
504 |a Omini, Moncada, Vane, The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG's) (1977) Prostaglandins, 14, p. 625 
504 |a Omini, Pasargiklin, Folco, Fano, Berti, Pharmacological activity of PGI2 and its metabolite 6-oxo-PGF1 on human uterus and fallopian tubes (1978) Prostaglandins, 15, p. 1045 
504 |a Cho, Allen, Chemical stability of prostacyclin (PGI2) in aqueous solution (1978) Prostaglandins, 15, p. 943 
504 |a Dusting, Moncada, Vane, Recirculation of prostacyclin (PGI2) in the dog (1978) Br. J. Pharmacol., 64, p. 315 
504 |a Borda, Lazzari, Gimeno, Gimeno, Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin like material (PGI2) produced by the rat stomach fundus (1980) Prostaglandins, 19, p. 899 
504 |a Pifer, Cagen, Chesney, Stability of prostaglandin I2 in human blood (1981) Prostaglandins, 21, p. 165 
504 |a Sterin-Speziale, Gimeno, Bonacossa, Gimeno, The effect of estradiol on isolated rat uterine motility and on prostaglandin generation (1980) Prostaglandins, 20, p. 233 
504 |a Gimeno, Borda, Sterin-Borda, Vidal, Gimeno, Pharmacologic influences on human ovarian contractions (1976) Obstet. Gynecol., 47, p. 218 
504 |a Van Rossum, Cumulative dose-response curves (1963) Arch. Int. Pharmacodyn. Ther., 143, p. 299 
504 |a Bergström, Carñson, Weeks, The prostaglandins a family of biologically active lipids (1968) Pharmacol Rev, 20, p. 1 
504 |a Bygdeman, Green, Toppozada, Mirvist, Bergström, The influence of prostaglandin metabolites on the uterine response to PGF2. A clinical and pharmacokinetic study (1974) Life Sci., 14, p. 521 
504 |a Wong, Malik, Desiderio, McGiff, Sun, Hepatic metabolism of prostacyclin (PGI2) in the rabbit: formation of a potent novel inhibitor of platelet aggregation (1980) Biochem. Biophys. Res. Commun., 93, p. 486 
504 |a Wong, Lee, Chao, Reiss, McGiff, Metabolism of prostacyclin by 9-hydroxy prostaglandin dehydrogenase in human latelets (1980) J. Biol. Chem., 255, p. 9021 
504 |a Clark, Kennedy, Patrick, Challis, Effect of bisenoic prostaglandins on the uterine vasculature of the non-pregnant sheep (1981) Prostaglandins, 22, p. 333 
504 |a Borda, Agostini, Sterin-Speziale, Gimeno, Gimeno, Spontaneous contractile activity of isolated ovarian human vein. A dual influence of prostacyclin (PGI2) (1979) Prostaglandins, 18, p. 829 
504 |a Lye, Challis, Inhibition by PGI2 of myometrial activity in vivo in non-pregnant ovariectomized sheep (1982) J. Reprod. Fert., 66, p. 311 
504 |a Williams, El-Tahir, Marcinkiewicz, Dual actions of prostacyclin (PGI2) on the rat pregnant uterus (1979) Prostaglandins, 17, p. 667 
504 |a Gimeno, Sterin-Borda, Borda, Lazzari, Gimeno, Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance with contracts isolated bovine coronary arteries (1980) Prostaglandins, 19, p. 807 
520 3 |a Dose-response curves for several prostaglandins (PGI2; PGD2; PGF2 and PGE2); BaCl2 or prostaglandin metabolites (15-keto-PGF2α; 13, 14-diOH-15-keto-PGF2α; 6-keto-PGF1α and 6-keto-PGE1 in quiescent (indomethacin-treated) uterine strips from ovariectomized rats, were constructed. All PGs tested as well as BaCl2, triggered at different concentrations, evident phasic contractions. Within the range of concentrations tested the portion of the curves for the metabolites of PGF2α was shifted to the right of that for PGF2α itself; the curve for 6-keto-PGF1α was displaced to the right of the curve for PGI2 and that for 6-keto-PGE1 to the left. It was also demonstrated that the uterine motility elicited by 10-5 M PGF2α and its metabolites was long lasting (more than 3 hours) and so it was the activity evoked by PGI2; 6-keto-PGF1α and BaCl2, but not the contractions following 6-keto-PGE1, which disappeared much earlier. The contractile tension after PGF2α; 15-keto-PGF2α; 13, 14-diOH-15-keto-PGF2α and PGI2, increased as time progressed whilst that evoked by 6-keto-PGF2α or BaCl2 fluctuated during the same period around more constant levels. The surprising sustained and gradually increasing contractile activity after a single dose of an unstable prostaglandin such as PGI2, on the isolated rat uterus rendered quiescent by indomethacin, is discussed in terms of an effect associated to its transformation into more stable metabolites (6-keto-PGF1α, or another not tested) or as a consequence of a factor which might protects prostacyclin from inactivation. © 1983.  |l eng 
536 |a Detalles de la financiación: Centro de Estudios Farmacologicos y de Principios (CEFAPRIN), Consejo National de Investigaciones Tecnicas de la Repljblica Argentina (CONICET). (1414) Buenos Aires, Argentina. 
536 |a Detalles de la financiación: work has been supported by Grant 6638 from CDNICET. 
593 |a Centro de Estudios Farmacológicos y de Principios Naturales (CEFAPRIN), Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET). Serr, 1414 Buenos Aires, Argentina 
690 1 0 |a BARIUM CHLORIDE 
690 1 0 |a INDOMETACIN 
690 1 0 |a PROSTACYCLIN 
690 1 0 |a PROSTAGLANDIN D2 
690 1 0 |a PROSTAGLANDIN E2 
690 1 0 |a PROSTAGLANDIN F2 ALPHA 
690 1 0 |a ANIMAL CELL 
690 1 0 |a BIOLOGICAL MODEL 
690 1 0 |a DOSE RESPONSE 
690 1 0 |a DOSE TIME EFFECT RELATION 
690 1 0 |a DRUG ADMINISTRATION 
690 1 0 |a DRUG COMPARISON 
690 1 0 |a DRUG EFFICACY 
690 1 0 |a DRUG RESPONSE 
690 1 0 |a FEMALE GENITAL SYSTEM 
690 1 0 |a METHODOLOGY 
690 1 0 |a MYOMETRIUM 
690 1 0 |a NONHUMAN 
690 1 0 |a RAT 
690 1 0 |a UTERUS CONTRACTILITY 
690 1 0 |a ANIMALS 
690 1 0 |a BARIUM 
690 1 0 |a BARIUM COMPOUNDS 
690 1 0 |a CASTRATION 
690 1 0 |a CHLORIDES 
690 1 0 |a DINOPROST 
690 1 0 |a DINOPROSTONE 
690 1 0 |a DOSE-RESPONSE RELATIONSHIP, DRUG 
690 1 0 |a EPOPROSTENOL 
690 1 0 |a FEMALE 
690 1 0 |a INDOMETHACIN 
690 1 0 |a PROSTAGLANDIN D2 
690 1 0 |a PROSTAGLANDINS D 
690 1 0 |a PROSTAGLANDINS E 
690 1 0 |a PROSTAGLANDINS F 
690 1 0 |a RATS 
690 1 0 |a RATS, INBRED STRAINS 
690 1 0 |a UTERINE CONTRACTION 
690 1 0 |a ANIMALIA 
700 1 |a Chaud, M. 
700 1 |a Bonacossa, A. 
700 1 |a Franchi, A.M. 
700 1 |a Gimeno, M.F. 
773 0 |d 1983  |g v. 26  |h pp. 663-676  |k n. 4  |p Prostaglandins  |x 00906980  |t Prostaglandins 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021048161&doi=10.1016%2f0090-6980%2883%2990202-2&partnerID=40&md5=df89bdaf09073948fa65a83c4b91b605  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/0090-6980(83)90202-2  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00906980_v26_n4_p663_Gimeno  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00906980_v26_n4_p663_Gimeno  |y Registro en la Biblioteca Digital 
961 |a paper_00906980_v26_n4_p663_Gimeno  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 79337